NEW YORK ( TheStreet) -- CHANGE IN RATINGS Accenture ( ACN) was upgraded at Societe Generale to hold from sell. $75 price target. Estimates were also boosted, given an improvement in Europe. Ariad Pharma ( ARIA) was upgraded at Oppenheimer to outperform from perform. $24 price target. Company has a solid pipeline, which should drive near-term growth, Oppenheimer said. Colgate-Palmolive ( CL) was upgraded at Morgan Stanley to overweight. $68 price target. Company can generate above-average sales growth and deserves a higher multiple, Morgan Stanley said. Chipotle ( CMG) was upgraded at Morgan Stanley to overweight. $485 price target. Company can continue to raise prices, Morgan Stanley said. JCI) was downgraded at Morgan Stanley to underweight from overweight. Valuation call, based on a $40 price target, Morgan Stanley said. JC Penney ( JCP) was downgraded at Maxim Group to hold from buy. Company is seeing lower sales and rising debt, Maxim Group said. Marathon Oil ( MRO) was upgraded at Argus to buy from hold. $42 price target. Company is leveraged to higher oil prices, Argus said. Estimates also boosted. PNRA) was downgraded at Morgan Stanley to equal-weight. Company may struggle to raise prices, Morgan Stanley said. Whitewave Foods ( WWAV) was downgraded at BMO Capital to underperform. $17 price target. Sales growth will likely decelerate in the coming years, BMO Capital said. Xilinx ( XLNX) was upgraded at Pacific Crest to outperform from sector perform. $55 price target. Company should benefit from the LTE upgrade in China, Pacific Crest said.